Anti-TSpan7 autoantibodies are detected relatively infrequently, in approximately 5–10% of newly diagnosed T1D patients, underscoring their status as a minor autoantigen [84]. This evidence concerns the gene TSPAN7 and type 1 diabetes mellitus.